Audientes (AUDNTS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
2 Jun, 2026Executive summary
Expanded global market presence with a focus on Europe, China, India, Japan, and MENA, leveraging e-commerce, partnerships, and product localization.
Transitioning from a product-focused to a software platform and licensing business model, with first licensee in China and ongoing OEM dialogues in Japan and Europe.
Strategic positioning in the high-growth hearing solutions industry, with next-gen product development and scalable licensing underway.
Early-stage revenue with late-stage execution, leveraging proven technology and scalable licensing.
Emphasizing partnerships, e-commerce, and new product launches to drive future growth.
Financial highlights
Q1 2025 product sales revenue reached TDKK 80, up from TDKK 15 in Q1 2024, but below commercial targets.
EBITDA was negative at TDKK -1,607, compared to TDKK -1,316 in Q1 2024, due to increased investments in marketing and market entry.
Net loss for Q1 2025 was TDKK -3,011, compared to TDKK -2,601 in Q1 2024.
Cash and cash equivalents at quarter-end were TDKK 4, with an equity ratio of 6.1%.
Free cash flow for Q1 2025 was TDKK -465, an improvement from TDKK -605 in Q1 2024.
Outlook and guidance
Negative EBITDA expected for 2025, with cash flow breakeven targeted in H2 2026, supported by a planned DKK 15 million corporate bond issuance in June 2025.
Focus on accelerating e-commerce, expanding licensing/OEM models, and scaling in Europe, Japan, and Asia.
Additional working capital likely required in late 2026, with preference for non-dilutive funding.
Anticipates strong revenue growth in 2025 and 2026 as new products and partnerships mature.
Growth in NRE and licensing revenue anticipated from 2026 product collaborations.
Latest events from Audientes
- Expanded in Asia/Europe, improved losses, and revised 2024 outlook; growth expected in 2025.AUDNTS
Q3 20242 Jun 2026 - 2024 saw market expansion and cost cuts, but revenue missed targets and funding needs persist.AUDNTS
Q4 20242 Jun 2026 - Weak Q2 results and negative equity, but new orders and bond plans set up H2 2025 recovery.AUDNTS
Q2 20252 Jun 2026 - Delayed revenue and negative equity highlight urgent need for new funding and partnerships.AUDNTS
Q3 20251 Dec 2025 - H1 2024 revenue fell sharply as Audientes expanded in Asia and revised its outlook amid funding needs.AUDNTS
Q2 202413 Jun 2025